| |
| |
|
| Insider
Information: |
Stamoulis Christiana |
| Relationship: |
EVP & Chief Financial ... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
176,167 |
|
|
Indirect Shares
|
939 |
|
|
| Direct
Value |
$28,353,517 |
|
|
|
Indirect Value
|
$453,575 |
|
|
| Total
Shares |
177,106 |
|
|
| Total
Value |
$28,807,092 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
SVP, Corp Strategy & B... |
2013-07-15 |
40,712 |
2013-07-15 |
939 |
Premium* |
|
|
Hologic Inc |
HOLX |
Director |
2024-03-07 |
45,472 |
2011-11-01 |
0 |
Premium* |
|
|
Incyte Corp |
INCY |
EVP & Chief Financial ... |
2024-02-14 |
89,983 |
2019-02-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Strategy & Bus Devlp |
• – – |
2010-10-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
320 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Strategy & Bus Devlp |
• – – |
2010-10-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13,238 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Strategy & Bus Devlp |
• – – |
2011-02-03 |
4 |
A |
$0.01 |
$102 |
D/D |
10,166 |
23,813 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Strategy & Bus Devlp |
• – – |
2013-02-05 |
4 |
A |
$0.01 |
$102 |
D/D |
10,166 |
45,712 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Strategy & Bus Devlp |
• – – |
2013-04-29 |
4 |
AS |
$79.08 |
$6,598,756 |
D/D |
(82,999) |
40,712 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Strategy & Bus Devlp |
• – – |
2013-04-29 |
4 |
OE |
$33.82 |
$2,687,144 |
D/D |
77,999 |
123,711 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Strategy & Bus Devlp |
• – – |
2013-04-30 |
4 |
AS |
$77.88 |
$78 |
D/D |
(1) |
40,712 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Strategy & Bus Devlp |
• – – |
2013-04-30 |
4 |
OE |
$34.57 |
$35 |
D/D |
1 |
40,713 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Strategy & Bus Devlp |
• – – |
2013-05-15 |
4 |
AS |
$79.48 |
$47,949 |
D/D |
(602) |
40,712 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Strategy & Bus Devlp |
• – – |
2013-07-05 |
4 |
AS |
$80.65 |
$380,615 |
D/D |
(4,687) |
40,712 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Strategy & Bus Devlp |
• – – |
2013-07-05 |
4 |
OE |
$34.57 |
$162,030 |
D/D |
4,687 |
45,399 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Strategy & Bus Devlp |
• – – |
2013-07-15 |
4 |
OE |
$33.82 |
$38,048 |
D/D |
1,125 |
41,837 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Strategy & Bus Devlp |
• – – |
2013-07-15 |
4 |
AS |
$86.25 |
$97,139 |
D/D |
(1,125) |
40,712 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP & Chief Financial Officer |
• – – |
2019-02-11 |
4 |
A |
$80.21 |
$824,960 |
D/D |
10,285 |
10,285 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP & Chief Financial Officer |
• – – |
2020-02-11 |
4 |
D |
$76.14 |
$59,389 |
D/D |
(780) |
14,089 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP & Chief Financial Officer |
• – – |
2020-02-11 |
4 |
A |
$76.14 |
$324,966 |
D/D |
4,268 |
14,869 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP & Chief Financial Officer |
• – – |
2020-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,661 |
21,067 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP & Chief Financial Officer |
• – – |
2020-11-16 |
4 |
A |
$0.00 |
$0 |
D/D |
1,232 |
22,299 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP & Chief Financial Officer |
• – – |
2021-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
11,522 |
33,821 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP & Chief Financial Officer |
• – – |
2021-02-11 |
4 |
D |
$84.99 |
$102,838 |
D/D |
(1,210) |
32,611 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP & Chief Financial Officer |
• – – |
2021-07-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(516) |
40,265 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP & Chief Financial Officer |
• – – |
2021-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,853 |
40,781 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP & Chief Financial Officer |
• – – |
2022-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
14,463 |
57,462 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP & Chief Financial Officer |
• – – |
2022-02-11 |
4 |
D |
$66.76 |
$78,577 |
D/D |
(1,177) |
56,285 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP & Chief Financial Officer |
• – – |
2022-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
17,317 |
73,783 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
